Trials / Unknown
UnknownNCT03915275
Clinical Impact of 16S rDNA PCR
Clinical Impact of 16S rDNA PCR, a Monocentric Retrospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- —
Summary
The main objective of this study is to evaluate the impact of a positive 16S rDNA PCR in various sites on patient's management. The secondary objectives of the protocol are: * to evaluate bacterial identification performance * to evaluate the effect of previous antibiotic therapy * to analyze the management of discordant results between 16S PCR and culture identification
Conditions
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2019-04-16
- Last updated
- 2019-04-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03915275. Inclusion in this directory is not an endorsement.